Literature DB >> 3826958

Esophageal testing of patients with noncardiac chest pain or dysphagia. Results of three years' experience with 1161 patients.

P O Katz, C B Dalton, J E Richter, W C Wu, D O Castell.   

Abstract

Records from 910 patients referred to our clinical esophageal manometry laboratory for evaluation of noncardiac chest pain between January 1983 and December 1985 were reviewed and compared with records from 251 patients referred for dysphagia. Evaluation included baseline esophageal manometry, acid perfusion test, and edrophonium provocation. In the chest-pain group, 655 patients (72%) had normal esophageal motility and 255 (28%) had abnormal motility. Nutcracker esophagus was present in 48% of abnormal tracings, suggesting that it is a manometric marker for noncardiac chest pain. Of the total chest-pain group, 243 patients (27%) had their pain reproduced during provocative testing ("definite" esophageal pain); 192 patients (21%) had baseline manometric abnormalities but no pain during provocative testing ("probable" esophageal chest pain). The highest percentage of positive provocative responses (34%) occurred in patients with nutcracker esophagus on baseline manometry. Manometric abnormalities were statistically commoner (p less than 0.001) in patients with dysphagia, occurring in 53%. Achalasia (36%) and nonspecific esophageal motility disorders (38%) were the commonest abnormalities in this group, with nutcracker esophagus being infrequent (10%).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3826958     DOI: 10.7326/0003-4819-106-4-593

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  103 in total

1.  Relationship between manometric findings and reported symptoms in nutcracker esophagus: insights gained from a review of 313 patients.

Authors:  Kazuto Tsuboi; Sumeet K Mittal; András Legner; Fumiaki Yano; Charles J Filipi
Journal:  J Gastroenterol       Date:  2010-06-09       Impact factor: 7.527

2.  Phenotypes and clinical context of hypercontractility in high-resolution esophageal pressure topography (EPT).

Authors:  Sabine Roman; John E Pandolfino; Joan Chen; Lubomyr Boris; Daniel Luger; Peter J Kahrilas
Journal:  Am J Gastroenterol       Date:  2011-09-20       Impact factor: 10.864

3.  Comparison of esophageal motility in patients with solid dysphagia and mixed dysphagia.

Authors:  Chien-Lin Chen; William C Orr
Journal:  Dysphagia       Date:  2005       Impact factor: 3.438

4.  Esophageal manometry in the evaluation of esophageal symptoms.

Authors:  D O Castell
Journal:  Dysphagia       Date:  1992       Impact factor: 3.438

5.  Clinical and manometric course of nonspecific esophageal motility disorders.

Authors:  Michaela Müller; Alexander J Eckardt; Björn Göpel; Volker F Eckardt
Journal:  Dig Dis Sci       Date:  2011-10-18       Impact factor: 3.199

6.  Emergency department assessment of acute-onset chest pain: contemporary approaches and their consequences.

Authors:  Thomas C Gerber; Michael C Kontos; Birgit Kantor
Journal:  Mayo Clin Proc       Date:  2010-04       Impact factor: 7.616

7.  Successful use of phosphodiesterase type 5 inhibitors to control symptomatic esophageal hypercontractility: a case report.

Authors:  Amit Agrawal; Radu Tutuian; Amine Hila; Donald O Castell
Journal:  Dig Dis Sci       Date:  2005-11       Impact factor: 3.199

8.  Recurrent autonomous esophageal peristalsis in patients with chest discomfort.

Authors:  T E Nixon; K L Koch
Journal:  Dig Dis Sci       Date:  1989-04       Impact factor: 3.199

9.  Esophageal visceral pain sensitivity: effects of TENS and correlation with manometric findings.

Authors:  M Börjesson; M Pilhall; T Eliasson; H Norssell; C Mannheimer; P Rolny
Journal:  Dig Dis Sci       Date:  1998-08       Impact factor: 3.199

10.  Ambulatory esophageal manometry, pH-metry, and Holter ECG monitoring in patients with atypical chest pain.

Authors:  W G Paterson; H Abdollah; I T Beck; L R Da Costa
Journal:  Dig Dis Sci       Date:  1993-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.